News & Updates

GI infections fuel severe symptoms in immune-mediated diarrhoea, colitis

20 Aug 2021

Concomitant gastrointestinal (GI) infections contribute to more severe symptoms in patients with immune-mediated diarrhoea and colitis (IMDC), a recent study has shown. Antimicrobial therapy neither shuns the need for immunosuppressive treatment for IMDC nor improves clinical outcomes.

GI infections fuel severe symptoms in immune-mediated diarrhoea, colitis

20 Aug 2021

Vision impairment ups risks for dementia, cognitive decline in older adults

20 Aug 2021 by

Older adults with vision impairment are at higher risk of both dementia and cognitive impairment, according to a study.

Vision impairment ups risks for dementia, cognitive decline in older adults

20 Aug 2021

Oral intake of advanced gastric cancer patients worsens in later-line chemotherapy

20 Aug 2021

Later-line chemotherapy does not seem to improve oral intake in patients with advanced gastric cancer (AGC), which is why careful adaptation of regimens is necessary for those at risk for impaired oral intake, suggests a recent study.

Oral intake of advanced gastric cancer patients worsens in later-line chemotherapy

20 Aug 2021

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

20 Aug 2021 by

In individuals with neurogenic detrusor overactivity incontinence (NDOI) who were regularly undergoing clean intermittent catheterization, significant reductions of urinary incontinence episodes were seen following treatment with abobotulinumtoxinA (aboBoNT-A), according to a pooled analysis of two CONTENT studies presented at EAU 2021.

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

20 Aug 2021

Unmet needs hurt emotional wellbeing of caregivers of cancer patients

20 Aug 2021 by

Having unmet daily needs harms the emotional state of family cancer caregivers (FCC), especially during the intermediate and chronic treatment phases of the disease, according to a recent Singapore study.

Unmet needs hurt emotional wellbeing of caregivers of cancer patients

20 Aug 2021

Probiotics, synbiotics beneficial in gestational diabetes

20 Aug 2021

Interventions involving supplementation with probiotics or synbiotics help manage glucose and lipid concentrations, as well as exert anti-inflammation and antioxidant benefits in diet-controlled patients with gestational diabetes mellitus, according to the results of a meta-analysis.

Probiotics, synbiotics beneficial in gestational diabetes

20 Aug 2021

Pulmonary function foretells chronic heart failure outcome

20 Aug 2021

Forced expiratory volume in one second is predictive of progression of chronic heart failure, according to data from the MyoVasc study.

Pulmonary function foretells chronic heart failure outcome

20 Aug 2021

Postpancreatitis diabetes mellitus common but often treated as type 2 diabetes

20 Aug 2021

Postpancreatitis diabetes mellitus (PPDM) occurs frequently in adults and is a common type of secondary diabetes, a study reports. Furthermore, PPDM is often misclassified and treated as type 2 diabetes, contrary to its requirement for special management considerations.

Postpancreatitis diabetes mellitus common but often treated as type 2 diabetes

20 Aug 2021

Tenofovir alafenamide may prevent HBV mother-to-child transmission

19 Aug 2021 by

Tenofovir alafenamide (TAF), administered during the second or third trimester of pregnancy, may prevent mother-to-child transmission (MTCT) of hepatitis B virus (HBV) infection, according to two studies presented as posters at ILC 2021.

Tenofovir alafenamide may prevent HBV mother-to-child transmission

19 Aug 2021

Very low-dose sacubitril/valsartan feasible for HFrEF patients with drug intolerance

19 Aug 2021

Initiation of treatment with low doses of sacubitril/valsartan (SV) appears to be effective for heart failure with reduced ejection fraction (HFrEF) even in patients suspected to be intolerant to the drug regimen, according to a recent study. Low-dose SV results in comparable changes in N-terminal brain natriuretic peptide (NT-proBNP) as its standard dose counterpart.

Very low-dose sacubitril/valsartan feasible for HFrEF patients with drug intolerance

19 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

GI infections fuel severe symptoms in immune-mediated diarrhoea, colitis

GI infections fuel severe symptoms in immune-mediated diarrhoea, colitis

Vision impairment ups risks for dementia, cognitive decline in older adults

Vision impairment ups risks for dementia, cognitive decline in older adults

Oral intake of advanced gastric cancer patients worsens in later-line chemotherapy

Oral intake of advanced gastric cancer patients worsens in later-line chemotherapy

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

Unmet needs hurt emotional wellbeing of caregivers of cancer patients

Unmet needs hurt emotional wellbeing of caregivers of cancer patients

Probiotics, synbiotics beneficial in gestational diabetes

Probiotics, synbiotics beneficial in gestational diabetes

Pulmonary function foretells chronic heart failure outcome

Pulmonary function foretells chronic heart failure outcome

Postpancreatitis diabetes mellitus common but often treated as type 2 diabetes

Postpancreatitis diabetes mellitus common but often treated as type 2 diabetes

Tenofovir alafenamide may prevent HBV mother-to-child transmission

Tenofovir alafenamide may prevent HBV mother-to-child transmission

Very low-dose sacubitril/valsartan feasible for HFrEF patients with drug intolerance

Very low-dose sacubitril/valsartan feasible for HFrEF patients with drug intolerance